Deutsch English Français

Contact

EP3350168

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3350168

EP3350168 - SULFINYLPHENYL OR SULFONIMIDOYLPHENYL BENZAZEPINES [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 23.10.2020 Database last updated on 02.11.2024
Former	The patent has been granted Status updated on 15.11.2019
Former	Grant of patent is intended Status updated on 16.09.2019
Former	Examination is in progress Status updated on 29.03.2019
Former	Request for examination was made Status updated on 22.06.2018
Former	The international publication has been made Status updated on 25.03.2017
Most recent event Tooltip	08.07.2022	Lapse of the patent in a contracting state New state(s): MK	published on 10.08.2022 [2022/32]
Applicant(s)	For all designated states F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH
	[2018/30]
Inventor(s)	01 / HOVES, Sabine Schlossbergstrasse 6 82392 Habach / DE
	02 / WANG, Lisha c/o F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH
	03 / YUN, Hongying c/o Roche R&D Center (China) Ltd Building 5 No. 720 Cailun Road Shanghai 201203 / CN
	04 / ZHANG, Weixing c/oRoche R&D Center (China) Ltd Building 5 No. 720 Cailun Road Shanghai 201203 / CN
	05 / ZHU, Wei c/o Roche R&D Center (China) Ltd Building 5 No. 720 Cailun Road Shanghai 201203 / CN
	[2018/30]
Representative(s)	Klostermeyer-Rauber, Dörte F. Hoffmann-La Roche AG Corporate Law Patents (CLP) Grenzacherstrasse 124 4070 Basel / CH
	[2018/30]
Application number, filing date	16763865.9	14.09.2016
	[2018/30]
	WO2016EP71613
Priority number, date	WO2015CN89868	17.09.2015 Original published format: PCT/CN2015/089868
	[2018/30]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2017046112
	Date:	23.03.2017
	Language:	EN
	[2017/12]
	Type:	A1 Application with search report
	No.:	EP3350168
	Date:	25.07.2018
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 23.03.2017 takes the place of the publication of the European patent application.
	[2018/30]
	Type:	B1 Patent specification
	No.:	EP3350168
	Date:	18.12.2019
	Language:	EN
	[2019/51]
Search report(s)	International search report - published on:	EP	23.03.2017
Classification	IPC:	C07D223/16, C07D401/04, A61K31/55, A61P29/00	[2018/30]
	CPC:	C07D223/16 (EP,US); A61P11/06 (EP); A61P29/00 (EP); A61P31/00 (EP); A61P35/00 (EP); A61P37/02 (EP); (+) A61P37/04 (EP); A61P37/06 (EP); A61P37/08 (EP); A61P43/00 (EP); C07D401/04 (EP,US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/30]
Extension states	BA	Not yet paid
	ME	Not yet paid
Validation states	MA	Not yet paid
	MD	Not yet paid
Title	German:	SULFINYLPHENYL ODER SULFONIMIDOYLPHENYL BENZAZEPINE	[2019/41]
	English:	SULFINYLPHENYL OR SULFONIMIDOYLPHENYL BENZAZEPINES	[2018/30]
	French:	BENZAZÉPINES SULFINYLPHENYL OU SULFONIMIDOYL	[2019/41]
	Former [2018/30]	SULFINYLPHENYL- ODER SULFONIMIDPHENYL-BENZAZEPINE
	Former [2018/30]	BENZAZÉPINES DE SULFINYLPHÉNYLE OU DE SULFONIMIDOYLPHÉNYLE
Entry into regional phase	17.04.2018	National basic fee paid
	17.04.2018	Designation fee(s) paid
	17.04.2018	Examination fee paid
Examination procedure	22.02.2018	Date on which the examining division has become responsible
	17.04.2018	Examination requested [2018/30]
	29.10.2018	Amendment by applicant (claims and/or description)
	02.04.2019	Despatch of a communication from the examining division (Time limit: M04)
	02.08.2019	Reply to a communication from the examining division
	17.09.2019	Communication of intention to grant the patent
	05.11.2019	Fee for grant paid
	05.11.2019	Fee for publishing/printing paid
	05.11.2019	Receipt of the translation of the claim(s)
Opposition(s)	21.09.2020	No opposition filed within time limit [2020/48]
Fees paid	Renewal fee
	11.09.2018	Renewal fee patent year 03
	11.09.2019	Renewal fee patent year 04
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	HU	14.09.2016
	AL	18.12.2019
	AT	18.12.2019
	CY	18.12.2019
	CZ	18.12.2019
	DK	18.12.2019
	EE	18.12.2019
	ES	18.12.2019
	FI	18.12.2019
	HR	18.12.2019
	IT	18.12.2019
	LT	18.12.2019
	LV	18.12.2019
	MC	18.12.2019
	MK	18.12.2019
	MT	18.12.2019
	NL	18.12.2019
	PL	18.12.2019
	RO	18.12.2019
	RS	18.12.2019
	SE	18.12.2019
	SI	18.12.2019
	SK	18.12.2019
	SM	18.12.2019
	TR	18.12.2019
	BG	18.03.2020
	NO	18.03.2020
	GR	19.03.2020
	IS	18.04.2020
	PT	13.05.2020
	IE	14.09.2020
	LU	14.09.2020
	[2022/32]
Former [2022/28]	HU	14.09.2016
	AL	18.12.2019
	AT	18.12.2019
	CY	18.12.2019
	CZ	18.12.2019
	DK	18.12.2019
	EE	18.12.2019
	ES	18.12.2019
	FI	18.12.2019
	HR	18.12.2019
	IT	18.12.2019
	LT	18.12.2019
	LV	18.12.2019
	MC	18.12.2019
	MT	18.12.2019
	NL	18.12.2019
	PL	18.12.2019
	RO	18.12.2019
	RS	18.12.2019
	SE	18.12.2019
	SI	18.12.2019
	SK	18.12.2019
	SM	18.12.2019
	TR	18.12.2019
	BG	18.03.2020
	NO	18.03.2020
	GR	19.03.2020
	IS	18.04.2020
	PT	13.05.2020
	IE	14.09.2020
	LU	14.09.2020
Former [2022/27]	HU	14.09.2016
	AL	18.12.2019
	AT	18.12.2019
	CY	18.12.2019
	CZ	18.12.2019
	DK	18.12.2019
	EE	18.12.2019
	ES	18.12.2019
	FI	18.12.2019
	HR	18.12.2019
	IT	18.12.2019
	LT	18.12.2019
	LV	18.12.2019
	MT	18.12.2019
	NL	18.12.2019
	PL	18.12.2019
	RO	18.12.2019
	RS	18.12.2019
	SE	18.12.2019
	SI	18.12.2019
	SK	18.12.2019
	SM	18.12.2019
	TR	18.12.2019
	BG	18.03.2020
	NO	18.03.2020
	GR	19.03.2020
	IS	18.04.2020
	PT	13.05.2020
	IE	14.09.2020
	LU	14.09.2020
Former [2021/37]	AL	18.12.2019
	AT	18.12.2019
	CZ	18.12.2019
	DK	18.12.2019
	EE	18.12.2019
	ES	18.12.2019
	FI	18.12.2019
	HR	18.12.2019
	IT	18.12.2019
	LT	18.12.2019
	LV	18.12.2019
	NL	18.12.2019
	PL	18.12.2019
	RO	18.12.2019
	RS	18.12.2019
	SE	18.12.2019
	SI	18.12.2019
	SK	18.12.2019
	SM	18.12.2019
	BG	18.03.2020
	NO	18.03.2020
	GR	19.03.2020
	IS	18.04.2020
	PT	13.05.2020
	IE	14.09.2020
	LU	14.09.2020
Former [2021/27]	AL	18.12.2019
	AT	18.12.2019
	CZ	18.12.2019
	DK	18.12.2019
	EE	18.12.2019
	ES	18.12.2019
	FI	18.12.2019
	HR	18.12.2019
	IT	18.12.2019
	LT	18.12.2019
	LV	18.12.2019
	NL	18.12.2019
	PL	18.12.2019
	RO	18.12.2019
	RS	18.12.2019
	SE	18.12.2019
	SI	18.12.2019
	SK	18.12.2019
	SM	18.12.2019
	BG	18.03.2020
	NO	18.03.2020
	GR	19.03.2020
	IS	18.04.2020
	PT	13.05.2020
	LU	14.09.2020
Former [2021/10]	AL	18.12.2019
	AT	18.12.2019
	CZ	18.12.2019
	DK	18.12.2019
	EE	18.12.2019
	ES	18.12.2019
	FI	18.12.2019
	HR	18.12.2019
	IT	18.12.2019
	LT	18.12.2019
	LV	18.12.2019
	NL	18.12.2019
	PL	18.12.2019
	RO	18.12.2019
	RS	18.12.2019
	SE	18.12.2019
	SI	18.12.2019
	SK	18.12.2019
	SM	18.12.2019
	BG	18.03.2020
	NO	18.03.2020
	GR	19.03.2020
	IS	18.04.2020
	PT	13.05.2020
Former [2020/51]	AL	18.12.2019
	AT	18.12.2019
	CZ	18.12.2019
	DK	18.12.2019
	EE	18.12.2019
	ES	18.12.2019
	FI	18.12.2019
	HR	18.12.2019
	LT	18.12.2019
	LV	18.12.2019
	NL	18.12.2019
	RO	18.12.2019
	RS	18.12.2019
	SE	18.12.2019
	SI	18.12.2019
	SK	18.12.2019
	SM	18.12.2019
	BG	18.03.2020
	NO	18.03.2020
	GR	19.03.2020
	IS	18.04.2020
	PT	13.05.2020
Former [2020/47]	AL	18.12.2019
	CZ	18.12.2019
	DK	18.12.2019
	EE	18.12.2019
	ES	18.12.2019
	FI	18.12.2019
	HR	18.12.2019
	LT	18.12.2019
	LV	18.12.2019
	NL	18.12.2019
	RO	18.12.2019
	RS	18.12.2019
	SE	18.12.2019
	SK	18.12.2019
	SM	18.12.2019
	BG	18.03.2020
	NO	18.03.2020
	GR	19.03.2020
	IS	18.04.2020
	PT	13.05.2020
Former [2020/40]	AL	18.12.2019
	CZ	18.12.2019
	EE	18.12.2019
	FI	18.12.2019
	HR	18.12.2019
	LT	18.12.2019
	LV	18.12.2019
	NL	18.12.2019
	RO	18.12.2019
	RS	18.12.2019
	SE	18.12.2019
	SK	18.12.2019
	SM	18.12.2019
	BG	18.03.2020
	NO	18.03.2020
	GR	19.03.2020
	IS	18.04.2020
	PT	13.05.2020
Former [2020/37]	AL	18.12.2019
	CZ	18.12.2019
	EE	18.12.2019
	FI	18.12.2019
	HR	18.12.2019
	LT	18.12.2019
	LV	18.12.2019
	NL	18.12.2019
	RO	18.12.2019
	RS	18.12.2019
	SE	18.12.2019
	SK	18.12.2019
	SM	18.12.2019
	BG	18.03.2020
	NO	18.03.2020
	GR	19.03.2020
	PT	13.05.2020
Former [2020/36]	AL	18.12.2019
	CZ	18.12.2019
	EE	18.12.2019
	FI	18.12.2019
	HR	18.12.2019
	LT	18.12.2019
	LV	18.12.2019
	NL	18.12.2019
	RO	18.12.2019
	RS	18.12.2019
	SE	18.12.2019
	BG	18.03.2020
	NO	18.03.2020
	GR	19.03.2020
	PT	13.05.2020
Former [2020/35]	AL	18.12.2019
	CZ	18.12.2019
	FI	18.12.2019
	HR	18.12.2019
	LT	18.12.2019
	LV	18.12.2019
	NL	18.12.2019
	RO	18.12.2019
	RS	18.12.2019
	SE	18.12.2019
	BG	18.03.2020
	NO	18.03.2020
	GR	19.03.2020
Former [2020/32]	AL	18.12.2019
	FI	18.12.2019
	HR	18.12.2019
	LT	18.12.2019
	LV	18.12.2019
	NL	18.12.2019
	RS	18.12.2019
	SE	18.12.2019
	BG	18.03.2020
	NO	18.03.2020
	GR	19.03.2020
Former [2020/25]	FI	18.12.2019
	HR	18.12.2019
	LT	18.12.2019
	LV	18.12.2019
	RS	18.12.2019
	SE	18.12.2019
	BG	18.03.2020
	NO	18.03.2020
	GR	19.03.2020
Former [2020/23]	FI	18.12.2019
	LT	18.12.2019
	LV	18.12.2019
	SE	18.12.2019
	BG	18.03.2020
	NO	18.03.2020
	GR	19.03.2020
Former [2020/22]	FI	18.12.2019
	LT	18.12.2019
	SE	18.12.2019
	BG	18.03.2020
	NO	18.03.2020
Former [2020/21]	NO	18.03.2020
Cited in	International search	[Y]WO2007024612 (ARRAY BIOPHARMA INC [US], et al) [Y] 1-21 * page 1 - page 3; example 10; claim - *;
		[Y]WO2011022508 (VENTIRX PHARMACEUTICALS INC [US], et al) [Y] 1-21 * page 1 - page 3; example -; claim - *;
		[Y]WO2011022509 (VENTIRX PHARMACEUTICALS INC [US], et al) [Y] 1-21 * page 1 - page 3; example -; claim - *;
		[Y]WO2012097173 (VENTIRX PHARMACEUTICALS INC [US], et al) [Y] 1-21 * page 1 - page 3; example -; claim - *;
		[YP]WO2016096778 (HOFFMANN LA ROCHE [CH], et al) [YP] 1-21* page 1 - page 2; example -; claim - *
	by applicant	WO9215582
		WO2007024612
		WO2009111337
		WO2010093436
		WO2011017611
		WO2011068233
		WO2011139348
		WO2012066336
		WO2012167081
		WO2013033345
		US2013202629
		WO2013166110
		- KAWAI ET AL., IMMUNITY, (2011), vol. 34, pages 637 - 650
		- KAWAI ET AL., NAT. IMMUNOL., (2010), vol. 11, pages 373 - 384
		- HENESSY ET AL., NAT. REV. DRAG DISCOVERY, (2010), vol. 9, pages 293 - 307
		- BEKEREDJIAN-DING ET AL., J. IMMUNOLOGY, (2005), vol. 174, pages 4043 - 4050
		- CHEN ET AL., RNA, (2013), vol. 19, pages 737 - 739
		- CROS ET AL., IMMUNITY, (2010), vol. 33, pages 375 - 386
		- PANG ET AL., BMC IMMUNOLOGY, (2011), vol. 12, page 55
		- HOLLDACK, DRUG DISCOVERY TODAY, (2013), pages 1 - 4
		- GOODMAN, The Pharmacological Basis of Therapeutics, MACMILLAN PUBL. COMPANY, (1985), page 35

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p